This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
News|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
February 2005
Author(s)Pharmaceutical Technology Editors
Pharmaceutical Science & Technology News
Advertisement
Articles in this issue
almost 22 years ago
Correcting the Coursealmost 22 years ago
Good Work and True: USP Prepares for Convention 2005almost 22 years ago
Contract Manufacturers Getting Squeezedalmost 22 years ago
In the Spotlight-February 2005almost 22 years ago
Emerging Analytical Technology: Moving from the Lab to the Linealmost 22 years ago
Drug Safety Fears May Limit Reimporting and Shape R&Dalmost 22 years ago
In Defense of USP Singlet TestingAdvertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
The FDA approves asundexian, the first factor XIa inhibitor, cutting stroke risk 26% and setting a regulatory benchmark for factor XI drug developers.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
No operator touches a CAR-T batch before demonstrating proficiency. Generative AI users should meet the same standard, and a higher one, because an AI error does not stay inside one batch.
The FDA grants accelerated approval to subcutaneous amivantamab for head and neck cancer, extending the IV-to-subcutaneous shift in biologics formulation.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Manufacturing Intelligence: AI Poisoning Demands Pharma Data Stewards
2
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
3
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
4
Investing in Protecting Pharma Products
5